Conference Coverage
Media
NewsNetwork
OncLive® TV
Peer Exchange
Insights
Podcasts
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community

Register for a live webcast-"A New CD38-Directed Antibody for the Treatment of Appropriate Relapsed Refractory Multiple Myeloma Patients"

SPECIALTY TOPICS
CURRENTLY VIEWING
Mantle Cell Lymphoma
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology®
Neoadjuvant HER2+
More >>

Mantle Cell Lymphoma

Goy Underscores Impact of BTK Inhibitors in Relapsed/Refractory MCL
Goy Underscores Impact of BTK Inhibitors in Relapsed/Refractory MCL
Andre Goy, MD, MS, discusses the utility of BTK inhibitors in patients with relapsed/refractory mantle cell lymphoma. 
Read More >>
 
top border
View Conference Coverage
top border
Featured Programs
Ibrutinib in Relapsed Mantle Cell Lymphoma
Drs Danilov, Goy, Leonard, Pagel, and Schuster, discuss ibrutinib (Imbruvica) as a treatment in relapsed mantle cell lymphoma. View Now

Brad S. Kahl, MD, and Richard R. Furman, MD, explain available treatment options for relapsed mantle cell lymphoma. View Now

 

Featured Video
Dr. Tan on the Risk of Novel Coronavirus for Patients With Cancer
Daniel Petrylak, MD, and Nicholas Vogelzang, MD, share insight on the emerging role of chemotherapy in metastatic prostate cancer. View now
Publication Bottom Border
Border Publication
 
x